References
- Mello SS, Attardi LD. Not all p53 gain-of-function mutants are created equal. Cell Death Differ 2013; 20:855 - 7; http://dx.doi.org/10.1038/cdd.2013.53; PMID: 23749181
- Deb D, Scian M, Roth KE, Li W, Keiger J, Chakraborti AS, Deb SP, Deb S. Hetero-oligomerization does not compromise ‘gain of function’ of tumor-derived p53 mutants. Oncogene 2002; 21:176 - 89; http://dx.doi.org/10.1038/sj.onc.1205035; PMID: 11803461
- Olive KP, Tuveson DA, Ruhe ZC, Yin B, Willis NA, Bronson RT, Crowley D, Jacks T. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell 2004; 119:847 - 60; http://dx.doi.org/10.1016/j.cell.2004.11.004; PMID: 15607980
- Okawa T, Michaylira CZ, Kalabis J, Stairs DB, Nakagawa H, Andl CD, Johnstone CN, Klein-Szanto AJ, El-Deiry WS, Cukierman E, et al. The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation. Genes Dev 2007; 21:2788 - 803; http://dx.doi.org/10.1101/gad.1544507; PMID: 17974918
- Grugan KD, Vega ME, Wong GS, Diehl JA, Bass AJ, Wong KK, Nakagawa H, Rustgi AK. A common p53 mutation (R175H) activates c-Met receptor tyrosine kinase to enhance tumor cell invasion. Cancer Biol Ther 2013; 14; Forthcoming PMID: 23792586
- Fang Y, Han SI, Mitchell C, Gupta S, Studer E, Grant S, Hylemon PB, Dent P. Bile acids induce mitochondrial ROS, which promote activation of receptor tyrosine kinases and signaling pathways in rat hepatocytes. Hepatology 2004; 40:961 - 71; PMID: 15382121
- Yacoub A, Miller A, Caron RW, Qiao L, Curiel DA, Fisher PB, Hagan MP, Grant S, Dent P. Radiotherapy-induced signal transduction. Endocr Relat Cancer 2006; 13:Suppl 1 S99 - 114; http://dx.doi.org/10.1677/erc.1.01271; PMID: 17259563
- Sturla LM, Amorino G, Alexander MS, Mikkelsen RB, Valerie K, Schmidt-Ullrichr RK. Requirement of Tyr-992 and Tyr-1173 in phosphorylation of the epidermal growth factor receptor by ionizing radiation and modulation by SHP2. J Biol Chem 2005; 280:14597 - 604; http://dx.doi.org/10.1074/jbc.M413287200; PMID: 15708852
- Xu Y, Zhou J, Carey TE, McHugh JB, Voorhees JJ, Fisher GJ. Receptor-type Protein tyrosine phosphatase β regulates met phosphorylation and function in head and neck squamous cell carcinoma. Neoplasia 2012; 14:1015 - 22; PMID: 23226095